Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.9900 (-1.53%) ($8.9800 - $8.9900) on Tue. Sep. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.04% (three month average) | RSI | 58 | Latest Price | $8.9900(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT advances 0.4% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(72%) XBI(71%) IBB(60%) ARKK(59%) IBUY(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.02% in a week (0% probabilities). TBT(-25%) UUP(-16%) VXX(-11%) VIXM(-10%) URA(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.02% (StdDev 4.04%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $9.04(-0.55%) | 10 Day Moving Average | $9.01(-0.22%) | 20 Day Moving Average | $8.87(1.35%) | To recent high | -21.8% | To recent low | 12.3% | Market Cap | $558m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |